Cargando…
Drug Nanoparticle Formulation Using Ascorbic Acid Derivatives
Drug nanoparticle formulation using ascorbic acid derivatives and its therapeutic uses have recently been introduced. Hydrophilic ascorbic acid derivatives such as ascorbyl glycoside have been used not only as antioxidants but also as food and pharmaceutical excipients. In addition to drug solubiliz...
Autores principales: | , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3095256/ https://www.ncbi.nlm.nih.gov/pubmed/21603195 http://dx.doi.org/10.1155/2011/138929 |
_version_ | 1782203617095188480 |
---|---|
author | Moribe, Kunikazu Limwikrant, Waree Higashi, Kenjirou Yamamoto, Keiji |
author_facet | Moribe, Kunikazu Limwikrant, Waree Higashi, Kenjirou Yamamoto, Keiji |
author_sort | Moribe, Kunikazu |
collection | PubMed |
description | Drug nanoparticle formulation using ascorbic acid derivatives and its therapeutic uses have recently been introduced. Hydrophilic ascorbic acid derivatives such as ascorbyl glycoside have been used not only as antioxidants but also as food and pharmaceutical excipients. In addition to drug solubilization, drug nanoparticle formation was observed using ascorbyl glycoside. Hydrophobic ascorbic acid derivatives such as ascorbyl mono- and di-n-alkyl fatty acid derivatives are used either as drugs or carrier components. Ascorbyl n-alkyl fatty acid derivatives have been formulated as antioxidants or anticancer drugs for nanoparticle formulations such as micelles, microemulsions, and liposomes. ASC-P vesicles called aspasomes are submicron-sized particles that can encapsulate hydrophilic drugs. Several transdermal and injectable formulations of ascorbyl n-alkyl fatty acid derivatives were used, including ascorbyl palmitate. |
format | Text |
id | pubmed-3095256 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | Hindawi Publishing Corporation |
record_format | MEDLINE/PubMed |
spelling | pubmed-30952562011-05-20 Drug Nanoparticle Formulation Using Ascorbic Acid Derivatives Moribe, Kunikazu Limwikrant, Waree Higashi, Kenjirou Yamamoto, Keiji J Drug Deliv Review Article Drug nanoparticle formulation using ascorbic acid derivatives and its therapeutic uses have recently been introduced. Hydrophilic ascorbic acid derivatives such as ascorbyl glycoside have been used not only as antioxidants but also as food and pharmaceutical excipients. In addition to drug solubilization, drug nanoparticle formation was observed using ascorbyl glycoside. Hydrophobic ascorbic acid derivatives such as ascorbyl mono- and di-n-alkyl fatty acid derivatives are used either as drugs or carrier components. Ascorbyl n-alkyl fatty acid derivatives have been formulated as antioxidants or anticancer drugs for nanoparticle formulations such as micelles, microemulsions, and liposomes. ASC-P vesicles called aspasomes are submicron-sized particles that can encapsulate hydrophilic drugs. Several transdermal and injectable formulations of ascorbyl n-alkyl fatty acid derivatives were used, including ascorbyl palmitate. Hindawi Publishing Corporation 2011 2011-04-26 /pmc/articles/PMC3095256/ /pubmed/21603195 http://dx.doi.org/10.1155/2011/138929 Text en Copyright © 2011 Kunikazu Moribe et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Article Moribe, Kunikazu Limwikrant, Waree Higashi, Kenjirou Yamamoto, Keiji Drug Nanoparticle Formulation Using Ascorbic Acid Derivatives |
title | Drug Nanoparticle Formulation Using Ascorbic Acid Derivatives |
title_full | Drug Nanoparticle Formulation Using Ascorbic Acid Derivatives |
title_fullStr | Drug Nanoparticle Formulation Using Ascorbic Acid Derivatives |
title_full_unstemmed | Drug Nanoparticle Formulation Using Ascorbic Acid Derivatives |
title_short | Drug Nanoparticle Formulation Using Ascorbic Acid Derivatives |
title_sort | drug nanoparticle formulation using ascorbic acid derivatives |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3095256/ https://www.ncbi.nlm.nih.gov/pubmed/21603195 http://dx.doi.org/10.1155/2011/138929 |
work_keys_str_mv | AT moribekunikazu drugnanoparticleformulationusingascorbicacidderivatives AT limwikrantwaree drugnanoparticleformulationusingascorbicacidderivatives AT higashikenjirou drugnanoparticleformulationusingascorbicacidderivatives AT yamamotokeiji drugnanoparticleformulationusingascorbicacidderivatives |